The U.S. v. Doud Litigation Documents consist of pleadings, trial exhibits, and transcripts.
On February 2, 2022, a jury convicted Laurence F. Doud III of conspiring to unlawfully distribute oxycodone and fentanyl and of conspiring to defraud the Drug Enforcement Administration (DEA). He was sentenced to 27 months in prison.
Doud was charged for actions related to his role as CEO of pharmaceutical distributor Rochester Drug Cooperative (“RDC”) between 2012 and 2017. Doud and other defendants with RDC failed to report suspicious pharmacy orders (such as unusual sales volumes, cash purchases, and out-of-state purchasers) to the DEA, misrepresented RDC’s adherence to written compliance policies and procedures, and failed to conduct due diligence on new customers who purchased opioids and other narcotics.
The records in this collection were provided to OIDA by the U.S. Attorney’s Office for the Southern District of New York.
Documents in the collection include email correspondence, DEA reports and reporting logs, pharmacy order records, Automation of Reports and Consolidated Orders System (ARCOS) reports, as well as call logs and transcripts. The documents detail the wholesale distribution process, sales and market share information of wholesalers, as well as compliance and audit reports submitted to the DEA.
Names frequently appearing in the documents are Laurence “Larry” Doud; William Pietruszewski, Operations Manager; and Julius Morton, Chief Compliance Officer.
The Opioid Industry Documents Archive (OIDA) received documents with redactions.
